BioCentury
ARTICLE | Company News

MDxHealth sales and marketing update

October 26, 2015 7:00 AM UTC

MDxHealth launched in the Netherlands its SelectMDx for Prostate Cancer to identify patients at low risk for prostate cancer. The mRNA biomarker liquid biopsy diagnostic has CE Mark approval. MDxHealt...